Supplementary Table 3 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma

Supplementary Table 3 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma

<p>Supplementary Table 3 Uni- and multivariate Cox survival analysis using HJURP and NSD2 expression in myeloma dataset</p>

Đã lưu trong:

Chi tiết về thư mục
Tác giả chính:	Yunlu Jia (2012017) (author)
Tác giả khác:	Jianbiao Zhou (14935538) (author), Tze King Tan (15203447) (author), Tae-Hoon Chung (4343) (author), Yongxia Chen (424187) (author), Jing-Yuan Chooi (4238347) (author), Takaomi Sanda (15203450) (author), Melissa J. Fullwood (14195681) (author), Sinan Xiong (6175022) (author), Sabrina H.M. Toh (15203453) (author), Kalpnaa Balan (15203456) (author), Regina W.J. Wong (15203459) (author), Julia S.L. Lim (14935541) (author), Enfan Zhang (9965455) (author), Zhen Cai (576458) (author), Peng Shen (688111) (author), Wee Joo Chng (14959944) (author)
Được phát hành:	2025
Những chủ đề:	Cancer Cancer Biology Molecular and Cellular Biology Gene Regulation Mechanisms of transcription Hematological Cancers Myelomas Oncogenes & Tumor Suppressors Oncogenes
Các nhãn:	Thêm thẻ Không có thẻ, Là người đầu tiên thẻ bản ghi này!

Những quyển sách tương tự

Supplementary Table 1 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
Bằng: Yunlu Jia (2012017)
Được phát hành: (2025)

Supplementary Table 2 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
Bằng: Yunlu Jia (2012017)
Được phát hành: (2025)

Supplementary Table 5 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
Bằng: Yunlu Jia (2012017)
Được phát hành: (2025)

Supplementary Tables S1-14 from Genetic Heterogeneity and Tissue-specific Patterns of Tumors with Multiple <i>PIK3CA</i> Mutations
Bằng: Smruthy Sivakumar (15053536)
Được phát hành: (2025)

Table S1 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
Bằng: Lijun Yao (15292963)
Được phát hành: (2025)

Table S2 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
Bằng: Lijun Yao (15292963)
Được phát hành: (2025)

Table S3 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
Bằng: Lijun Yao (15292963)
Được phát hành: (2025)

Table S4 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
Bằng: Lijun Yao (15292963)
Được phát hành: (2025)

Table S5 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
Bằng: Lijun Yao (15292963)
Được phát hành: (2025)

Table S6 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
Bằng: Lijun Yao (15292963)
Được phát hành: (2025)

Supplementary Data S1 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Bằng: Keiji Kurata (15055090)
Được phát hành: (2025)

Supplementary Data S2 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Bằng: Keiji Kurata (15055090)
Được phát hành: (2025)

Supplementary Data S3 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
Bằng: Keiji Kurata (15055090)
Được phát hành: (2025)

Supplementary Spreadsheet S1 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Bằng: Eileen M. Boyle (15015425)
Được phát hành: (2025)

Supplementary Spreadsheet S10 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Bằng: Eileen M. Boyle (15015425)
Được phát hành: (2025)

Supplementary Spreadsheet S11 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Bằng: Eileen M. Boyle (15015425)
Được phát hành: (2025)

Supplementary Spreadsheet S12 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Bằng: Eileen M. Boyle (15015425)
Được phát hành: (2025)

Supplementary Spreadsheet S2 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Bằng: Eileen M. Boyle (15015425)
Được phát hành: (2025)

Supplementary Spreadsheet S3 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Bằng: Eileen M. Boyle (15015425)
Được phát hành: (2025)

Supplementary Spreadsheet S4 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Bằng: Eileen M. Boyle (15015425)
Được phát hành: (2025)

Supplementary Spreadsheet S5 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Bằng: Eileen M. Boyle (15015425)
Được phát hành: (2025)

Supplementary Spreadsheet S6 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Bằng: Eileen M. Boyle (15015425)
Được phát hành: (2025)

Supplementary Spreadsheet S7 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Bằng: Eileen M. Boyle (15015425)
Được phát hành: (2025)

Supplementary Spreadsheet S8 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Bằng: Eileen M. Boyle (15015425)
Được phát hành: (2025)

Supplementary Spreadsheet S9 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Bằng: Eileen M. Boyle (15015425)
Được phát hành: (2025)

Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan
Bằng: Kazuhito Suzuki (22688384)
Được phát hành: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
Bằng: Feng Wang (44414)
Được phát hành: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
Bằng: Feng Wang (44414)
Được phát hành: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
Bằng: Feng Wang (44414)
Được phát hành: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
Bằng: Feng Wang (44414)
Được phát hành: (2025)

Supplementary Movie 1 from The Macrophage-Associated LncRNA <i>MALR</i> Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer
Bằng: Jia Liu (15386858)
Được phát hành: (2025)

Supplementary Tables from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Bằng: Craig M. Goodwin (14955973)
Được phát hành: (2025)

Figure S1 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Bằng: Craig M. Goodwin (14955973)
Được phát hành: (2025)

Figure S1 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Bằng: Craig M. Goodwin (14955973)
Được phát hành: (2025)

Figure S1 page3 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Bằng: Craig M. Goodwin (14955973)
Được phát hành: (2025)

Figure S1 page4 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Bằng: Craig M. Goodwin (14955973)
Được phát hành: (2025)

Figure S2 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Bằng: Craig M. Goodwin (14955973)
Được phát hành: (2025)

Figure S2 page2 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Bằng: Craig M. Goodwin (14955973)
Được phát hành: (2025)

Figure S2 page3 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Bằng: Craig M. Goodwin (14955973)
Được phát hành: (2025)

Figure S3 page1 from Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i>Mutant Pancreatic Cancer
Bằng: Craig M. Goodwin (14955973)
Được phát hành: (2025)

Cannot write session to /tmp/vufind_sessions/sess_03a1gt5vegdipt877tubnr2j8m